Innovation isn't always the safest field. Here's what to consider within incident reporting. Graphic by Miguel Tovar/University of Houston

Exploding refrigerator? Chemical splash on the face? These are not just personally devastating lab incidents, they are also expensive.

For instance, awhile back, the University of Hawaii faced a total $115,500 fine for 15 workplace safety violations after a laboratory explosion where a postdoctoral researcher lost one of her arms. Beryl Lieff Benderly wrote in Science that the accident “resulted from a static electricity charge that ignited a tank containing a highly flammable, pressurized mixture of hydrogen, oxygen and carbon dioxide.”

Referred to as “incidents,” they are defined by University of California Santa Barbara (UCSB) in this way: “An incident is an event that results in or causes injury or damage to someone or something, or an event that has the potential to result in or cause injury or damage.”

But when asked which incidents are reportable, the answer is uniform across all research universities: all incidents must be reported.

Incidentally...

There are websites dedicated to laboratory accidents, like this one at UCSB. It lists the two accidents mentioned in this blog’s first sentence. University of Michigan Environment, Health and Safety’s website said, “Being safe at the University of Michigan requires a positive safety culture where we learn from mistakes and near-misses in order to improve and prevent future occurrences. It is vital that you report all ‘incidents’ including near- misses, injuries resulting from your activities, non-compliance with safety and environmental rules, and general unsafe work conditions so that we can learn and grow.” Northwestern University’s website on Research Health and Safety said, “Always report ‘near-misses’ just as you would an incident that causes injury or harm to property.”

Near-missing

You may be asking, what constitutes a “near-miss”? At Western Kentucky University, for example: “A laboratory “near-miss” is an unplanned situation, where with minor changes to time or setting, could have easily resulted in damage or injury to person or property. A near-miss is characterized as having little, if any, immediate impact on individuals, processes, or the environment, but provides insight into accidents that could happen.” Laboratory near misses may cause chemical spills, explosions and bodily injury, but can be treated with first-aid.

Form finding

Most universities have a form to fill out if there is an incident that could have led to a severe injury or death. The form asks for a description of the incident and even asks, in some instances, “Why did it happen?” These should be made out comprehensively and quickly.

OSHA

The Occupational Safety and Health Administration (OSHA) has a reporting process, aside from what each university requires. They need information when you call. The OSHA website states: “Be prepared to supply: Business name; names of employees affected; location and time of the incident, brief description of the incident; contact person and phone number.”

There are even time limits for how quickly one must report a severe injury that requires an in-patient hospitalization, amputation or loss of an eye (24) or fatality.

(It’s eight hours.)

The fact that “losing an eye” is one of just four reasons to contact OSHA, you may wonder, “Are a lot of people blinded in the lab, often?” Also, “Where can I buy safety goggles?”

“Are a lot of people blinded in the lab, often? Also, where can I buy safety goggles?”

The big idea

There are many websites which detail lab disasters. Some are cautionary tales, some are avoidable situations. Just be sure to wear your Personal Protective Equipment (PPE) and be safe out there. Or rather, in there.

------

This article originally appeared on the University of Houston's The Big Idea. Sarah Hill, the author of this piece, is the communications manager for the UH Division of Research.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.